Blocking Super-enhancers, a New Treatment Approach for Asthma Patients

The new explanation for what causes the lungs’ airways to close during asthma attacks could change the way we manage and treat asthma. New study has discovered the role of IL-9 gene super-enhancers in the overproduction of mucin. The findings pave way for the development of new class of drugs that is radically different from the steroids currently used to treat asthma.

Led by Xian C. Li, M.D., Ph.D., and his colleagues in the Immunobiology and Transplant Science Center at the Houston Methodist Research Institute, the study is published in the Journal of Experimental Medicine.

Asthma - Factors, Common Allergens, Diagnosis, Treatment, Support Groups, FAQs
It's a lung condition characterized by inflammation of the bronchi and constriction of the airways that result in coughing, wheezing or breathlessness. Allergy and other airway irritants can trigger it

‘Chemical inhibitors were used to stop this assembly of IL-9 gene super-enhancers to prevent the production of IL-9, which in turn reduces mucin production in asthma patients.’

Tweet it Now

One of the key features of asthma is an overproduction of a highly sticky protein secreted by the mucous membranes of airways in the lungs, called mucin, which leads to plugging up the small airways and stopping air from traveling in and out of them. This leaves patients out of breath and, oftentimes, causes them to gasp for air.

Li and his team discovered an interaction between two molecules that can be manipulated to solve this problem. "If we can do this and develop better and more specific drugs to selectively stop super-enhancers, asthmatic patients may never have to struggle for air again," he said.

A new explanation

Breathe-in or Ingestible Antibody can Help Prevent Allergy, Asthma
The ingestible or inhalable antibody prevents allergic reactions and asthma in adults, by binding to molecules which would otherwise cause allergy.

Li explained that the inner lining of the elaborate lung airways is made up of epithelial cells that allow air to travel in and out, and this inner lining keeps the airways open.

"Embedded in these epithelial cells are a very important cell type called mucin-producing cells that are vital for keeping the epithelial surface moisturized and healthy, and they secrete mucin to protect the surface of the airways. Production of mucin is normally tightly controlled, but too much of it can be damaging," he said.

Asthma Costs Over $80 Billion Per Year for the US Economy
Cost of asthma increases the burden of the disease on affected patients and the US economy.

Central to their findings was the identification of T helper cells that communicate with mucin-producing cells in the lungs through a small protein called interleukin 9 (IL-9). These T helper cells are a specialized type of white blood cells responsible for helping other cells in the immune system recognize foreign toxins by secreting IL-9 to regulate immune responses.

In asthma, the T helper cells in the lungs are hyperactive and express a molecule called OX40. To help immune cells survive, OX40 organizes super-enhancers, which are regions of DNA that control what genes become active, causing T helper cells to produce an abundance of IL-9. This, in turn, leads to massive production of mucin in the airways, eventually clogging them up.

Inclusion of Telemedicine to In-school Asthma Care Cuts Hospital Visits in Half
Addition of telemedicine to in-school care provides national model for urban-based asthma treatment in children.

"We were able to decipher how such great quantities of IL-9 are produced by T helper cells," Li said. "In essence, OX40 activates the IL-9 gene in T helper cells, leading to the overproduction of IL-9 through a powerful molecular machinery of super-enhancers that regulate gene expression."

Using chemical inhibitors, Li and his colleagues found a new way to stop this assembly of IL-9 gene super-enhancers to prevent the production of IL-9. This may point to new ways of treating asthma.

"Finding new approaches to target and block super-enhancers may provide a new means of treatment for asthma patients that is likely to be more efficacious than the standard of care, which is now steroids," Li said.

Source-Eurekalert